60 Degrees Pharmaceuticals Inc. (SXTP)
NASDAQ · Healthcare
60 Degrees Pharmaceuticals Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 1.0M | 607,574 | 253,573 | 223,208 | 1.2M | 2.2M |
| Gross Profit | 223,776 | 222,809 | -220,977 | -209,162 | 309,598 | 1.5M |
| Profitability | ||||||
| Operating Income | -7.8M | -9.7M | -5.2M | -1.8M | -1.1M | -368,914 |
| EBITDA | -7.5M | -9.5M | 241,942 | -1.7M | -1.0M | -341,170 |
| Net Income | -7.4M | -8.0M | -3.8M | -6.2M | -4.3M | -3.0M |
| Per Share Data | ||||||
| EPS (diluted) | $-11.73 | $-74.20 | $-11.88 | $-13.32 | $-9.16 | $-6.54 |
| Shares Outstanding (dil.) | 1M | 0M | 0M | 0M | 0M | 0M |
60 Degrees Pharmaceuticals Inc. Income Statement — FAQ
60 Degrees Pharmaceuticals Inc. (SXTP) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SXTP's income statement history?
The chart and table above show 60 Degrees Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.